At this time, posts about IntronBio are rapidly increasing on portals and securities communities. Today, foreigners have tentatively purchased a net 93,477 shares of IntronBio, while institutions have sold a net 2,000 shares. IntronBio is known as a manufacturer of biopharmaceuticals and alternatives to antibiotics for animals.
As of 1:30 PM on the 18th, IntronBio's stock price is 26,050 KRW, down 9.71% from the previous day, with a trading volume of 2,764,672 shares, which is 303.36% of the 5-day average trading volume.
In addition to IntronBio, posts by investors are also rapidly increasing for Jeongdawoon (208140), AT Semicon (089530), and Ginetics (303030).

※Source: AI Investment Assistant AI Lassi
※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
![Clutching a Stolen Dior Bag, Saying "I Hate Being Poor but Real"... The Grotesque Con of a "Human Knockoff" [Slate]](https://cwcontent.asiae.co.kr/asiaresize/183/2026021902243444107_1771435474.jpg)
